versicolorin c has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iijima, M; Kubota, Y; Kunisada, T; Momose, I; Nomoto, A; Sawa, R; Shibasaki, M; Someno, T; Tatsuda, D; Watanabe, T | 1 |
1 other study(ies) available for versicolorin c and Glioblastoma
| Article | Year |
|---|---|
Quinofuracins A-E, produced by the fungus Staphylotrichum boninense PF1444, show p53-dependent growth suppression.
Topics: Anthraquinones; Antineoplastic Agents; Ascomycota; Cell Death; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Japan; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Tumor Suppressor Protein p53 | 2015 |